| Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression. | None |
| Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification. | None |
| Drosophila von Hippel-Lindau tumor suppressor gene function in epithelial tubule morphogenesis. | None |
| The predicted 14 amino acid extended mutant von Hippel-Lindau tumor suppressor protein variant was stable and retained the ability to downregulate hypoxia-inducible factor 1 alpha in a hydroxylation dependent manner | None |
| The autosomal dominantly inherited disorder von Hippel-Lindau disease (VHL) is caused by germline mutations in the VHL tumour suppressor gene (TSG). (Review) | None |
| Myb-binding protein p160 is a novel target of the von Hippel-Lindau tumor suppressor. | None |
| Cancer cells promote survival through depletion of the von Hippel-Lindau tumor suppressor by protein crosslinking. | None |
| results suggest a novel mechanism of regulation of the VHL tumor suppressor by TGase 2 that appears to be independent of the known cancer regulatory mechanisms | None |
| Von Hippel-Lindau gene product directs cytokinesis: a new tumor suppressor function. | None |
| Kelch-like 20 up-regulates the expression of hypoxia-inducible factor-2?? through hypoxia- and von Hippel-Lindau tumor suppressor protein-independent regulatory mechanisms. | None |
| The von Hippel-Lindau tumor suppressor protein promotes c-Cbl-independent poly-ubiquitylation and degradation of the activated EGFR. | None |
| The interaction of the von Hippel-Lindau tumor suppressor and heterochromatin protein 1. | None |
| PIAS4 interacts with the tumour suppressor von Hippel-Lindau (VHL) and leads to VHL sumoylation, oligomerization, and impaired function. | None |
| A novel function of pVHL and demonstrate a negative-feedback loop between pVHL and E2F1, which may shed new light on the explanation of the role of pVHL in tumour suppression. | None |
| Interaction between Nm23 and the tumor suppressor VHL | None |
| Data show the spectrum of von Hippel-Lindau disease tumor suppressor (VHL) protein mutations in Korean von Hippel-Lindau (VHL) disease. | None |
| RSUME is expressed in VHL tumors and inhibits VHL and regulates its tumor suppressor function. | None |
| Age-specific risk for CNS hemangioblastoma was significantly higher in subjects carrying missense mutations in alpha domain in exon 1; beta domain in exon 3 of von Hippel-Lindau tumor suppressor within the HIF-alpha binding site. | None |
| Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL) | None |
| Data show the interactions between von Hippel-Lindau tumor suppressor (VHL) and the cyclin-dependent kinase inhibitor family CDKN1 (p21, p27 and p57). | None |